These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 4395198)

  • 1. Effect of thioproperazine on 5-HIAA content in urine and cerebrospinal fluid of chronic schizophrenic patients.
    Albert JM; Palaic D; Tetreault L; Panisset JC DHAITI G; Desaty J
    Dis Nerv Syst; 1970 Nov; 31():Suppl:140-4. PubMed ID: 4395198
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effects of thioproperazine on the urinary excretion and concentration in the cerebrospinal fluid of 5-hydroxyindoleacetic acid in chronic schizophrenia].
    Albert JM; Palaic D; Tétreault L; Panisset JC; Dhaiti G; Desaty J
    Laval Med; 1971 Feb; 42(2):167-71. PubMed ID: 4396038
    [No Abstract]   [Full Text] [Related]  

  • 3. On the concentration of 5-hydroxyindoleacetic acid in schizophrenia: a meta-analysis.
    Tuckwell HC; Koziol JA
    Psychiatry Res; 1996 Jan; 59(3):239-44. PubMed ID: 8930029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effects of thioproperazine on dopamine and noradrenaline metabolism in chronic schizophrenia].
    Panisset VC; Albert JM; Rocheleau LP; Dhaiti G; Tétreault L
    Laval Med; 1970 Sep; 41(7):917-22. PubMed ID: 4396422
    [No Abstract]   [Full Text] [Related]  

  • 5. [Changes in the CSF levels of monoamine metabolites in 102 chronic schizophrenic patients following probenecid before and after neuroleptic medication].
    Chen YF
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1984 Oct; 17(5):273-7. PubMed ID: 6085683
    [No Abstract]   [Full Text] [Related]  

  • 6. Levels of HIAA and VMA in C.S.F. of schizophrenics before and after treatment.
    Okasha A; Eid SZ; Bishry Z; Lotaif F; Gouda JF
    J Egypt Med Assoc; 1978; 61(Suppl 1-2):38-50. PubMed ID: 95520
    [No Abstract]   [Full Text] [Related]  

  • 7. Low CSF 5-hydroxyindoleacetic acid in schizophrenic patients with enlarged cerebral ventricles.
    Potkin SG; Weinberger DR; Linnoila M; Wyatt RJ
    Am J Psychiatry; 1983 Jan; 140(1):21-5. PubMed ID: 6183980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of Deseril-Retard and Migristen on the excretion of 5-hydroxy-indoloacetic acid and P-hydroxy-M-methoxymandelic acid in the urine of patients suffering from migraine].
    Stein W; Kawiak W; Stelmasiak Z; Gieracz A
    Ann Univ Mariae Curie Sklodowska Med; 1969; 24():309-20. PubMed ID: 5406037
    [No Abstract]   [Full Text] [Related]  

  • 9. [Urinary excretion of 5-hydroxyindoleacetic acid by patients with chronic schizophrenia].
    Slowik S
    Psychiatr Pol; 1967; 1(1):45-52. PubMed ID: 5597271
    [No Abstract]   [Full Text] [Related]  

  • 10. [Changes in the levels of adrenergic and serotoninergic indices in patients with depressive states].
    Misionzhnik EIu; Vertogradova OP; Krasnov VN; Salenko BB
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1981; 81(4):543-51. PubMed ID: 6168150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [On the concentration of neuraminic acid in the serum and cerebrospinal fluid of patients with schizophrenia].
    Mikhaĭlova KM
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1969; 69(1):102-7. PubMed ID: 5771477
    [No Abstract]   [Full Text] [Related]  

  • 12. [Treatment of chronic schizophrenic psychoses with a thioridazine derivative].
    Glatzel J
    Med Welt; 1972 Jan; 23(2):62-4. PubMed ID: 5059991
    [No Abstract]   [Full Text] [Related]  

  • 13. Smooth pursuit eye movements, clinical symptoms, CSF metabolites, and skin conductance habituation in schizophrenic patients.
    Bartfai A; Levander SE; Sedvall G
    Biol Psychiatry; 1983 Sep; 18(9):971-87. PubMed ID: 6196060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 5-Hydroxyindoleacetic acid and homovanillic acid concentrations in cerebrospinal fluid in patients with Alzheimer's disease, depression and mild cognitive impairment.
    Stuerenburg HJ; Ganzer S; Müller-Thomsen T
    Neuro Endocrinol Lett; 2004 Dec; 25(6):435-7. PubMed ID: 15665806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concentrations of monoamine metabolites and chlorpromazine in cerebrospinal fluid for prediction of therapeutic response in psychotic patients treated with neuroleptic drugs.
    Sedvall G
    Prog Biochem Pharmacol; 1980; 16():133-40. PubMed ID: 6160594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cerebrospinal fluid biochemical examinations: do they reflect clinical or biological differences?
    Banki CM; Arató M; Papp Z
    Biol Psychiatry; 1983 Sep; 18(9):1033-44. PubMed ID: 6196059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Piperacetazine (Quide): a controlled evaluation of the elixir in chronic schizophrenic patients.
    Gallant DM; Bishop MP
    Curr Ther Res Clin Exp; 1970 Jun; 12(6):387-9. PubMed ID: 4987346
    [No Abstract]   [Full Text] [Related]  

  • 18. [Enzyme activity of the cerebrospinal fluid (CSF) in chronic schizophrenic patients].
    De Castro del Pozo S; Benito-Arranz S; Fernandez Sandonis J; Rodriguez Navarro I; Martinez Rivera L; Guerro Cerrato E
    Arch Neurobiol (Madr); 1971; 34(2):219-30. PubMed ID: 5563297
    [No Abstract]   [Full Text] [Related]  

  • 19. Changes in schizophrenic intelligence under thioproperazine therapy.
    Askar AM; el-Guindy T; Shaheen O
    J Egypt Med Assoc; 1969; 52(8):652-8. PubMed ID: 4391944
    [No Abstract]   [Full Text] [Related]  

  • 20. CSF 5-HIAA and suicide in non-depressed schizophrenics.
    van Praag HM
    Lancet; 1983 Oct; 2(8356):977-8. PubMed ID: 6195497
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.